2 天前 - … COVID-19 is an infectious disease caused by a novel coronavirus SARS-CoV-2. The
… the exposure of type 2 pneumocytes to the SARS-CoV-2 spike protein and is influenced by …

2 天前 - … SARS-CoV-2 is one of the most public health problems. In the absence of specific
therapy for coronavirus disease 2019 (COVID-19), … safety and anti-SARS-CoV-2 effectiveness …

2 天前 - … may provide protection against persistent COVID-19 symptoms. … for SARS-CoV-2,
which leaves the possibility that some of them may have been re-infected with Covid-19. …

2 天前 - … Our study shows that during the early stage of COVID-19 pandemic in 2020, antibiotics
… While in the early days of the COVID-19 pandemic antibiotic prescribing was full of trial …

2 天前 - … factor for severe coronavirus disease 2019 (COVID-19). … COVID-19 vaccines
in patients with CVD. Twenty-six patients with CVD who received monovalent mRNA COVID-19 …

2 天前 - … to vaccination and viral infection with SARS-CoV-2, incorporating immune memory
cells. … Therefore, the impact of these treatments on the post-acute sequelae of COVID-19 (…

2 天前 - … complications of severe COVID-19 and contributes to patient … Patients with ARDS
from COVID-19 may represent a … pathobiological pathways during COVID-19 ARDS. We …

2 天前 - … COVID-19 immune system dysregulation accompanied by altered body composition
during the COVID-19 pandemic has led to COVID-19… the immune response to SARS-CoV-2 …

2 天前 - … Using data obtained during the human confinement imposed by COVID-19, we
assessed the influence that mass tourism in the eastern Canary Islands may have on an …

2 天前 - … After propensity score matching was completed, data from 258,645 patients with
COVID-19 (COVID-19 group) and 258,645 patients without COVID-19 (non-COVID-19 group) …